Skip to main content

Table 1 Baseline demographic, clinical, and angiographic data of patients

From: HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease

N

Overall

No-event

3p-mace event

P value

300

269

31

 

Demographics

 Age, years

65.3 ± 10.2

65.2 ± 10.1

65.9 ± 11.1

0.708

 Male

193 (64.3%)

176 (65.4%)

17 (54.8%)

0.244

 BMI (kg/m2)

24.9 ± 2.4

24.9 ± 2.4

24.9 ± 2.5

0.975

 Systolic BP, mmHg

133.6 ± 22.3

133.2 ± 22.6

137.5 ± 19.2

0.316

 Diastolic BP, mmHg

77.7 ± 13.5

77.7 ± 13.6

78.2 ± 12.0

0.838

 Heart Rate,

82.1 ± 16.4

81.8 ± 16.5

84.9 ± 15.5

0.314

Medical history

 Diabetes duration, years

9.8 ± 7.0

9.7 ± 7.0

10.9 ± 6.8

0.366

 Hypertension

206 (68.7%)

180 (66.9%)

26 (83.9%)

0.054

 Stroke

28 (9.3%)

24 (8.9%)

4 (12.9%)

0.471

 ACEI/ARB

92 (30.7%)

80 (29.7%)

12 (38.7%)

0.305

 Insulin

98 (32.7%)

84 (31.2%)

4 (45.2%)

0.117

Laboratory values

 HbA1c, (%)

8.0 ± 1.8

7.9 ± 1.7

8.7 ± 2.4

0.013

 Fasting glucose, mmol/L

9.2 ± 4.2

9.1 ± 3.9

10.4 ± 5.8

0.095

 TC, mmol/L

4.5 ± 1.2

4.5 ± 1.2

4.6 ± 1.2

0.881

 TG, mmol/L

1.9 ± 1.2

1.8 ± 1.2

2.0 ± 1.4

0.514

 HDL-C, mmol/L

1.1 ± 0.3

1.0 ± 0.3

1.1 ± 0.4

0.080

 LDL-C, mmol/L

2.8 ± 0.9

2.8 ± 0.9

2.7 ± 0.8

0.629

 eGFR, mL/min/1.73 m2

83.4 ± 38.8

84.2 ± 39.2

76.1 ± 35.1

0.268

 BNP (pg/ml)

391.1 ± 680.8

395.1 ± 708.4

356.8 ± 366.6

0.767

 LVEF, %

59.6 ± 13.9

59.7 ± 14.3

58.9 ± 9.7

0.762

Angiographic data

 Gensini score

55.6 ± 41.5

54.8 ± 41.5

62.5 ± 41.2

0.328

 Myocardial infarction

102 (34.0%)

92 (34.2%)

10 (32.3%)

0.829

 PCI

179 (59.7%)

160 (59.5%)

19 (61.3%)

0.846

Severity of CHD

   

0.580

 Mild

92 (30.7%)

84 (31.2%)

8 (25.8%)

 

 Moderate

70 (23.3%)

64 (23.8%)

6 (19.4%)

 

 Sever

138 (46.0%)

121 (45.0%)

17 (54.8%)

 
  1. Values given as mean ± SD or number (percentage), ACEI: angiotensin-converting enzyme inhibitor, ARB: Angiotensin Receptor Blocker, TC: Total Cholesterol, TG: Triglyceride, HDL-C: High-Density Lipoprotein Cholesterol, LDL-C: Low-Density Lipoprotein Cholesterol, eGFR: estimated Glomerular Filtration Rate, LVEF: Left Ventricular Ejection Fraction, PCI: Percutaneous Coronary Intervention